[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Gene Silencing Market - Global Outlook and Forecast 2021-2027

April 2021 | 91 pages | ID: G0EA6F24AD62EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Gene Silencing in Global, including the following market information:

Global Gene Silencing Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Gene Silencing market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene Silencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gene Silencing Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Gene Silencing Market Segment Percentages, By Type, 2020 (%)
  • Transcriptional
  • Post-transcriptional
  • Meiotic
China Gene Silencing Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Gene Silencing Market Segment Percentages, By Application, 2020 (%)
  • Cancer Treatment
  • Neurological Diseases Treatment
  • Scar Treatment
  • Other
Global Gene Silencing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Gene Silencing Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Gene Silencing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Gene Silencing Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Alnylam Pharmaceuticals
  • Benitec Biopharma
  • Arrowhead Pharmaceuticals
  • Merck Group
  • Eli Lilly (Dicerna Pharmaceuticals)
  • Monsanto (Bayer AG)
  • RXi Pharmaceuticals
  • Silence Therapeutics plc
  • Idera Pharmaceuticals
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gene Silencing Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gene Silencing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GENE SILENCING OVERALL MARKET SIZE

2.1 Global Gene Silencing Market Size: 2021 VS 2027
2.2 Global Gene Silencing Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gene Silencing Players in Global Market
3.2 Top Global Gene Silencing Companies Ranked by Revenue
3.3 Global Gene Silencing Revenue by Companies
3.4 Top 3 and Top 5 Gene Silencing Companies in Global Market, by Revenue in 2020
3.5 Global Companies Gene Silencing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Silencing Players in Global Market
  3.6.1 List of Global Tier 1 Gene Silencing Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gene Silencing Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Gene Silencing Market Size Markets, 2021 & 2027
  4.1.2 Transcriptional
  4.1.3 Post-transcriptional
  4.1.4 Meiotic
4.2 By Type - Global Gene Silencing Revenue & Forecasts
  4.2.1 By Type - Global Gene Silencing Revenue, 2016-2021
  4.2.2 By Type - Global Gene Silencing Revenue, 2022-2027
  4.2.3 By Type - Global Gene Silencing Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gene Silencing Market Size, 2021 & 2027
  5.1.2 Cancer Treatment
  5.1.3 Neurological Diseases Treatment
  5.1.4 Scar Treatment
  5.1.5 Other
5.2 By Application - Global Gene Silencing Revenue & Forecasts
  5.2.1 By Application - Global Gene Silencing Revenue, 2016-2021
  5.2.2 By Application - Global Gene Silencing Revenue, 2022-2027
  5.2.3 By Application - Global Gene Silencing Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Gene Silencing Market Size, 2021 & 2027
6.2 By Region - Global Gene Silencing Revenue & Forecasts
  6.2.1 By Region - Global Gene Silencing Revenue, 2016-2021
  6.2.2 By Region - Global Gene Silencing Revenue, 2022-2027
  6.2.3 By Region - Global Gene Silencing Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Gene Silencing Revenue, 2016-2027
  6.3.2 US Gene Silencing Market Size, 2016-2027
  6.3.3 Canada Gene Silencing Market Size, 2016-2027
  6.3.4 Mexico Gene Silencing Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Gene Silencing Revenue, 2016-2027
  6.4.2 Germany Gene Silencing Market Size, 2016-2027
  6.4.3 France Gene Silencing Market Size, 2016-2027
  6.4.4 U.K. Gene Silencing Market Size, 2016-2027
  6.4.5 Italy Gene Silencing Market Size, 2016-2027
  6.4.6 Russia Gene Silencing Market Size, 2016-2027
  6.4.7 Nordic Countries Gene Silencing Market Size, 2016-2027
  6.4.8 Benelux Gene Silencing Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Gene Silencing Revenue, 2016-2027
  6.5.2 China Gene Silencing Market Size, 2016-2027
  6.5.3 Japan Gene Silencing Market Size, 2016-2027
  6.5.4 South Korea Gene Silencing Market Size, 2016-2027
  6.5.5 Southeast Asia Gene Silencing Market Size, 2016-2027
  6.5.6 India Gene Silencing Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Gene Silencing Revenue, 2016-2027
  6.6.2 Brazil Gene Silencing Market Size, 2016-2027
  6.6.3 Argentina Gene Silencing Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gene Silencing Revenue, 2016-2027
  6.7.2 Turkey Gene Silencing Market Size, 2016-2027
  6.7.3 Israel Gene Silencing Market Size, 2016-2027
  6.7.4 Saudi Arabia Gene Silencing Market Size, 2016-2027
  6.7.5 UAE Gene Silencing Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Alnylam Pharmaceuticals
  7.1.1 Alnylam Pharmaceuticals Corporate Summary
  7.1.2 Alnylam Pharmaceuticals Business Overview
  7.1.3 Alnylam Pharmaceuticals Gene Silencing Major Product Offerings
  7.1.4 Alnylam Pharmaceuticals Gene Silencing Revenue in Global (2016-2021)
  7.1.5 Alnylam Pharmaceuticals Key News
7.2 Benitec Biopharma
  7.2.1 Benitec Biopharma Corporate Summary
  7.2.2 Benitec Biopharma Business Overview
  7.2.3 Benitec Biopharma Gene Silencing Major Product Offerings
  7.2.4 Benitec Biopharma Gene Silencing Revenue in Global (2016-2021)
  7.2.5 Benitec Biopharma Key News
7.3 Arrowhead Pharmaceuticals
  7.3.1 Arrowhead Pharmaceuticals Corporate Summary
  7.3.2 Arrowhead Pharmaceuticals Business Overview
  7.3.3 Arrowhead Pharmaceuticals Gene Silencing Major Product Offerings
  7.3.4 Arrowhead Pharmaceuticals Gene Silencing Revenue in Global (2016-2021)
  7.3.5 Arrowhead Pharmaceuticals Key News
7.4 Merck Group
  7.4.1 Merck Group Corporate Summary
  7.4.2 Merck Group Business Overview
  7.4.3 Merck Group Gene Silencing Major Product Offerings
  7.4.4 Merck Group Gene Silencing Revenue in Global (2016-2021)
  7.4.5 Merck Group Key News
7.5 Eli Lilly (Dicerna Pharmaceuticals)
  7.5.1 Eli Lilly (Dicerna Pharmaceuticals) Corporate Summary
  7.5.2 Eli Lilly (Dicerna Pharmaceuticals) Business Overview
  7.5.3 Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Major Product Offerings
  7.5.4 Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Revenue in Global (2016-2021)
  7.5.5 Eli Lilly (Dicerna Pharmaceuticals) Key News
7.6 Monsanto (Bayer AG)
  7.6.1 Monsanto (Bayer AG) Corporate Summary
  7.6.2 Monsanto (Bayer AG) Business Overview
  7.6.3 Monsanto (Bayer AG) Gene Silencing Major Product Offerings
  7.6.4 Monsanto (Bayer AG) Gene Silencing Revenue in Global (2016-2021)
  7.6.5 Monsanto (Bayer AG) Key News
7.7 RXi Pharmaceuticals
  7.7.1 RXi Pharmaceuticals Corporate Summary
  7.7.2 RXi Pharmaceuticals Business Overview
  7.7.3 RXi Pharmaceuticals Gene Silencing Major Product Offerings
  7.4.4 RXi Pharmaceuticals Gene Silencing Revenue in Global (2016-2021)
  7.7.5 RXi Pharmaceuticals Key News
7.8 Silence Therapeutics plc
  7.8.1 Silence Therapeutics plc Corporate Summary
  7.8.2 Silence Therapeutics plc Business Overview
  7.8.3 Silence Therapeutics plc Gene Silencing Major Product Offerings
  7.8.4 Silence Therapeutics plc Gene Silencing Revenue in Global (2016-2021)
  7.8.5 Silence Therapeutics plc Key News
7.9 Idera Pharmaceuticals
  7.9.1 Idera Pharmaceuticals Corporate Summary
  7.9.2 Idera Pharmaceuticals Business Overview
  7.9.3 Idera Pharmaceuticals Gene Silencing Major Product Offerings
  7.9.4 Idera Pharmaceuticals Gene Silencing Revenue in Global (2016-2021)
  7.9.5 Idera Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Gene Silencing Market Opportunities & Trends in Global Market
Table 2. Gene Silencing Market Drivers in Global Market
Table 3. Gene Silencing Market Restraints in Global Market
Table 4. Key Players of Gene Silencing in Global Market
Table 5. Top Gene Silencing Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Gene Silencing Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Gene Silencing Revenue Share by Companies, 2016-2021
Table 8. Global Companies Gene Silencing Product Type
Table 9. List of Global Tier 1 Gene Silencing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Silencing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Gene Silencing Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Gene Silencing Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Gene Silencing Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Gene Silencing Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Gene Silencing Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Gene Silencing Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Gene Silencing Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Gene Silencing Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Gene Silencing Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Gene Silencing Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Gene Silencing Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Gene Silencing Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Gene Silencing Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Gene Silencing Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Gene Silencing Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Gene Silencing Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Gene Silencing Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Gene Silencing Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Gene Silencing Revenue, (US$, Mn), 2022-2027
Table 30. Alnylam Pharmaceuticals Corporate Summary
Table 31. Alnylam Pharmaceuticals Gene Silencing Product Offerings
Table 32. Alnylam Pharmaceuticals Gene Silencing Revenue (US$, Mn), (2016-2021)
Table 33. Benitec Biopharma Corporate Summary
Table 34. Benitec Biopharma Gene Silencing Product Offerings
Table 35. Benitec Biopharma Gene Silencing Revenue (US$, Mn), (2016-2021)
Table 36. Arrowhead Pharmaceuticals Corporate Summary
Table 37. Arrowhead Pharmaceuticals Gene Silencing Product Offerings
Table 38. Arrowhead Pharmaceuticals Gene Silencing Revenue (US$, Mn), (2016-2021)
Table 39. Merck Group Corporate Summary
Table 40. Merck Group Gene Silencing Product Offerings
Table 41. Merck Group Gene Silencing Revenue (US$, Mn), (2016-2021)
Table 42. Eli Lilly (Dicerna Pharmaceuticals) Corporate Summary
Table 43. Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Product Offerings
Table 44. Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Revenue (US$, Mn), (2016-2021)
Table 45. Monsanto (Bayer AG) Corporate Summary
Table 46. Monsanto (Bayer AG) Gene Silencing Product Offerings
Table 47. Monsanto (Bayer AG) Gene Silencing Revenue (US$, Mn), (2016-2021)
Table 48. RXi Pharmaceuticals Corporate Summary
Table 49. RXi Pharmaceuticals Gene Silencing Product Offerings
Table 50. RXi Pharmaceuticals Gene Silencing Revenue (US$, Mn), (2016-2021)
Table 51. Silence Therapeutics plc Corporate Summary
Table 52. Silence Therapeutics plc Gene Silencing Product Offerings
Table 53. Silence Therapeutics plc Gene Silencing Revenue (US$, Mn), (2016-2021)
Table 54. Idera Pharmaceuticals Corporate Summary
Table 55. Idera Pharmaceuticals Gene Silencing Product Offerings
Table 56. Idera Pharmaceuticals Gene Silencing Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Gene Silencing Segment by Type
Figure 2. Gene Silencing Segment by Application
Figure 3. Global Gene Silencing Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Gene Silencing Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Gene Silencing Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Silencing Revenue in 2020
Figure 8. By Type - Global Gene Silencing Revenue Market Share, 2016-2027
Figure 9. By Application - Global Gene Silencing Revenue Market Share, 2016-2027
Figure 10. By Region - Global Gene Silencing Revenue Market Share, 2016-2027
Figure 11. By Country - North America Gene Silencing Revenue Market Share, 2016-2027
Figure 12. US Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Gene Silencing Revenue Market Share, 2016-2027
Figure 16. Germany Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 17. France Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Gene Silencing Revenue Market Share, 2016-2027
Figure 24. China Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 28. India Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Gene Silencing Revenue Market Share, 2016-2027
Figure 30. Brazil Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Gene Silencing Revenue Market Share, 2016-2027
Figure 33. Turkey Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Gene Silencing Revenue, (US$, Mn), 2016-2027
Figure 37. Alnylam Pharmaceuticals Gene Silencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Benitec Biopharma Gene Silencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Arrowhead Pharmaceuticals Gene Silencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Merck Group Gene Silencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Monsanto (Bayer AG) Gene Silencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. RXi Pharmaceuticals Gene Silencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Silence Therapeutics plc Gene Silencing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications